A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight

NCT06973720 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

268

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight or Obesity

Interventions

DRUG: MET097
DRUG: Placebo

Sponsor

Metsera, a wholly owned subsidiary of Pfizer